Jake Wintermute of Ginkgo Bioworks Interview Transcribed and Summarized with ChatGPT with timestamps

The video is an episode of the “Learn with Lowell” show, where Lowell speaks with Jake Wintermute, a developer evangelist at Ginkgo Bioworks, about biotechnology, machine learning, and Ginkgo’s platform. They discuss the importance of values in the biotech industry and the parallels between the software and biotech industries in terms of intellectual property. They also touch on the cultured meat industry and the values-driven community around it.

Aubrey De Grey Interview Transcribed and Summarized with ChatGPT

Aubrey De Grey: Accelerating the Longevity Escape Velocity (LEV), mouse Trials, Yamanaka Factor -148 – YouTubehttps://www.youtube.com/watch?v=DHvoPlcWwg4 Episode summary The video features Aubrey De Grey, a scientist working on developing medical innovations that can postpone age-related…

Ginkgo Bioworks, Future of Biotechnology, ML, & codebase -Jake Wintermute – Learning with Lowell 178

Podcast: Play in new window | Download (Duration: 1:14:33 — 102.5MB) | Embed

Subscribe: Apple Podcasts | Spotify | Amazon Music | Android | Pandora | iHeartRadio | Podcast Index | TuneIn | RSS | More

Jake Wintermute is a Developer evangelist at Ginkgo bioworks.His mission is to grow the biotech ecosystem, to diversify the bioeconomy, and to provide education, documentation and support for developers bringing new projects to Ginkgo’s platform.

Missing Link between Metabolism, Longevity, & Healthspan -Michael Forrest – Learning with Lowell 177

Podcast: Play in new window | Download (Duration: 1:30:37 — 124.5MB) | Embed

Subscribe: Apple Podcasts | Spotify | Amazon Music | Android | Pandora | iHeartRadio | Podcast Index | TuneIn | RSS | More

Michael Forrest is a Cambridge university biochemistry graduate. Ph.D. computer science. Founder CEO of Biophysical Therapeutics, which is focused on drugs and interventions to slow aging and promote longevity.

A Cure for Alzheimer’s disease? – CEO of Leucadia Therapeutics Doug Ethell -Learning with Lowell 176

Podcast: Play in new window | Download (Duration: 1:22:00 — 112.6MB) | Embed

Subscribe: Apple Podcasts | Spotify | Amazon Music | Android | Pandora | iHeartRadio | Podcast Index | TuneIn | RSS | More

Doug Ethell is the founder and CEO of Leucadia Therapeutics, a pre-clinical stage company developing an early diagnostic for Alzheimer’s disease and a therapeutic device to stop that disorder in its earliest stages.